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HBsAg glomerular deposits in gtomerulonephritis: Fact or arti-
fact? To evaluate the role of the hepatitis B virus infection in the
pathogenesis of glomerulonephritis, we screened 136 consecu-
tive patients with various types of glomerular lesions for the
presence of HBsAg either in serum or in kidney biopsy speci-
mens by means of radioimmunoassay and direct immunofluores-
cence technique, respectively. In selected patients, we carried
out the search for antiglobulin activity (AA) factor(s) within the
renal tissue with a fluoresceinated aggregated human IgG
preparation (FITC-IgGagg). Eleven HBsAg seropositive patients
were found, none of whom showed HB5Ag deposits within their
kidney biopsy specimen. Five of the remaining 125 seronegative
patients, 3 with mixed cryoglobulinemia and 2 with lupus nephri-
tis, showed glomerular-positive staining with a rabbit fluores-
ceinated anti-HBs serum and deposits of 1gM endowed with AA,
along with IgG and complement factors. The presence of HBsAg
within the glomeruli was not confirmed, however, when a
fluoresceinated anti-HBs Fab' preparation was used instead of
the fluoresceinated anti-HBs serum. The pretreatment of the
tissue sections with unconjugated anti-IgM serum blocked the
direct staining for HB5Ag and FITC-IgGagg, but not that of the
other immunoreactants. Conclusion. The 1gM AA deposits may
interfere with the direct immunofluorescence testing for HBsAg,
leading to erroneous interpretation.
Dépôts glomerulaires d'HBsAg dans Ia glomérulonéphrite: Real-
ité ou artefact? Afin d'évaluer le role de l'infection par le virus de
l'hépatite B dans la physiopathologie de Ia glomerulonephrite,
136 malades consécutifs atteints de divers types de lesions
glomerulaires ont été étudiés pour Ia presence de HBsAg dans Ic
serum et dans les échantillons de biopsies rénales au moyen,
respectivement, d'un dosage radio-immunologique et de l'im-
munofluorescence. Dans un groupe de malades sélectionnés, Ia
recherche des facteurs dactivité antiglobuline (AA) dans le tissu
renal a été réalisée au moyen d'une preparation d'IgG humaine
agrégée fiuoresceinee (FITC-IgGagg). Onze malades séropositifs
pour HBsAg ont été identifies dont aucun n'avait de dépôt de
HBsAg dans le tissu renal. Cinq des 125 autres malades séronég-
atifs, 3 ayant une cryoglobulinemie mixte et 2 avec néphrite
lupique, avaient un rnarquage des glomerules par le serum anti
HBs fluorescent et des dépôts d'IgM ayant une activité antiglob-
uline, d'IgG et de facteurs du complement. La presence de
HBsAg dans le glomerule n'a pas été confirmée, cependant,
quand une preparation anti-HBs Fab fluoresceinée a été utilisée
au lieu du serum anti-HBs. Le pré-traitement des coupes avec du
serum anti 1gM non conjugué a bloqué le marquage direct pour
HBsAg et FITC-IgGagg mais pas celui des autres immunoréac-
tifs. Conclusion. Les depOts d'IgM AA peuvent interferer avec
l'évaluation de HBsAg par immunofluorescence directe et con-
duire a une interpretation erronée.
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Several observations suggest that the hepatitis B
virus (HBV) might be involved in the pathogenesis
of some forms of glomerulonephritis. Deposits of
HBsAg within the glomeruli along with
immunoglobulins and complement factors have
been detected occasionally in patients with gb-
merulonephritis [1—51, and when sought systemati-
cally, they were found in no less than 30% of the
children suffering from various forms of glomerulo-
nephritis [61. Moreover, circumstantial evidence
suggests that HBsAg immune complexes play a
pathogenic role in the glomerulonephritis associat-
ed to essential mixed cryoglobulinemia (EMC) [7,
81.
For an appraisal of the problem, since 1973 we
scrutinized all patients with glomerulonephritis
coming to our observation for the presence of
HBsAg in serum and in the kidney biopsy speci-
mens, and we present here the results of our studies
on the patients sorted out by either screening.
During a parallel study on the antiglobulin activity
(AA) within the kidney biopsy specimens of many
patients of the present series, we noted a close
relationship between the antiglobulin factor(s)
found within the gbomeruli and the positive
immunofluorescent staining of HBsAg. This obser-
vation prompted us to carry out special studies to
assess the possible interference of the antiglobulin
factor(s) with the immunofluorescent staining of
HBsAg, the results of which are included in the
present report.
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Methods
Patients. One hundred thirty-six consecutive pa-
tients with clinical and histologic evidence of gb-
merulopathy were studied (Table 1). The gbomeru-
lar lesions were classified, with minor modifica-
tions, according to the criteria of Habib [9].
Serologic assay. The HBsAg, anti-HBs, and anti-
HBc antibodies were assayed by radioimmunoas-
say (RIA) (kits AUSRIA 11, AUSAB, CORAB,
Abbott Laboratories) on sera that had been stored
at 80° C for as long as 5 years. The assay for
HBsAg was also performed by both counter-im-
munoelectrophoresis (Hapindex, Ortho) and pas-
sive hemagglutination (Hepanosticon, Organon
Teknika). The specificity of positive results for
HBsAg by RIA was checked by AUSAB confirma-
tory neutralization test. The titer of anti-HBs anti-
bodies was expressed in RIA units (RIA U). Serum
AA was detected by agglutination of IgG-coated
latex beads (Behring). Serum immunoglobulins G,
A, M, and complement factors C3, Clq, C4, and C3
Proactivator (C3PA) were measured by radial im-
munodiffusion; the total complement hemolytic ac-
tivity (CHSO), by a modification of the method
described by Kabat and Mayer [101.
Serum cryoglobulins were measured and ana-
lyzed as suggested by Grey and Köhler [11]. Each
of the cryogbobulin fraction, obtained through Seph-
adex G-200 chromatography, was tested for AA by
latex agglutination, and for HBsAg, anti-HBs, and
anti-HBc activities by RIA, having as controls both
human negative serum and its lgG fraction purified
through D EAE cellulose chromatography.
Immunopathologic study. For light microscopic
studies renal biopsy specimens were fixed in Du-
bosq-Brasil fluid and embedded in paraffin. Sec-
tions were cut 3 to 4 i. in thickness and stained with
hematoxilin-eosin, periodic acid-Shiff, Masson's
trichrome (light green), and in some cases with
periodic acid methenamine silver stains. Liver
specimens were processed with the same tech-
nique, and the tissue sections were stained with
hematoxilin-eosin and silver impregnation, accord-
ing to Gomori. A portion of each kidney biopsy
specimen was rapidly frozen in carbon dioxide and
cut in slices 4 to 5 thick. Direct immunofluores-
cent testings for HBsAg, human IgG, IgA, 1gM, C3,
Clq, C4, fibrinogen, and albumin were carried out
with rabbit monospecific antisera, all purchased
from Behring. The specificity of staining was ascer-
tained by blocking tests with unconjugated antisera.
To assess the specificity of the glomerular deposits,
we also tested some frozen tissue sections, which
had been stored at —80° C up to 5 years, with
fluoresceinated Fab' prepared from the commercial
rabbit antisera against HBsAg, IgG, 1gM, IgA
(Behring). The IgG fraction of each antiserum was
isolated by DEAE cellulose chromatography [121,
then submitted to pepsin digestion and dithiothrei-
tol reduction; the single peak isolated by Sephadex
G-75 chromatography was shown to contain only
Fab' when tested by immunoelectrophoresis with
goat anti rabbit IgG and anti-L chain sera. The Fab'
fractions were concentrated up to 1.6 to 2.0 mg/mI
and fluoresceinated [13]. The fluoresceinated Fab'
anti-HBs preparation showed specific activity up to
the dilution of 1 to 8 when tested on frozen liver
sections of 3 patients known to contain cytoplasmic
inclusions of the viral particles (Fig. I, a and b). The
FIBsAg staining was completely blocked by the
previous exposure of the liver tissue sections to the
unfluoresceinated anti-HBs Fab'. Each of the other
fluoresceinated Fab' preparations showed on se-
lected kidney biopsies staining specificity like the
corresponding fluoresceinated antiserum.
The search for the intrahepatic HBsAg and
HBcAg was carried out by direct immunofluores-
cence technique on frozen sections of liver tissue
with monospecific anti-HBs and anti-HBc sera.
(The anti-HBc serum was supplied by Dr. M.
Rizzetto, Gastroenterology Division, Hospital
Mauriziano Umberto 1°, Torino, Italy.)
The AA of glomerular immunoglobulin deposits
was evaluated on unfixed tissue sections with a
solution of fluoresceinated heat-aggregated human
IgG (FITC-lgGagg) prepared according to the meth-
od of Rossen et al [14, 151. The solution, containing
3 mg/mI of FITC-IgGagg, was stabilized by adding
bovine albumin to the final concentration of 0.5 gI
dl. The specificity of glomerular deposits with AA
was evaluated by blocking test with unconjugated
aggregated IgG (IgGagg). To identify the type of
glomerular deposits endowed with AA, we carried
out blocking tests by treating the tissue sections
with unconjugated antisera each specific for human
IgG, IgA, 1gM, and CIq, before the incubation with
the FITC-lgGagg. To evaluate the heat sensitivity
of the tissue AA, we heated the kidney tissue
sections at 60° C for 30 mm in PBS, and then we
treated them with the FITC-lgGagg [14, 15].
Results
Among the 136 patients studied, 11 had HBs
antigenemia by one or more assays (8%), and 5,
among those seronegative, showed in their kidney
biopsy specimens a positive reaction with the
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Table 1. Classification of glomerulonephritis in patients studied
Glomerular disease N





Proliferative diffuse intracapillary GN (PDIGN)
Proliferative diffuse intra and extracapillary GN (PDIEGN)
Membrano-proliferative GN (MPGN)
Membranous GN
Chronic sclerosing GN (CSGN)
Lupus glomerulonephritis (SLE-GN)
Essential mixed cryoglobulinemia GN (EMC-GN)
Mixed cryoglobulinemia GN in lynphoproliferative disorder
(LPD-GN)
Fig. 1. Staining of HBsAg liver inclusions with Afluoresceinated
anti-HBs Fab'; B fluoresceinated anti-HBs serum (x 360).
fluoresceinated anti-HBs serum. Our presentation
will be restricted to these 16 patients.
HBsAg seropositive patients. As shown by serial
serum assays, in all the 11 seropositive patients, the
antigenemia lasted longer than 6 months. The re-
sults of the laboratory and immunohistopathologic
studies, shown in Tables 2 and 3, indicated the
presence of other markers of HBV infection and/or
liver histologic changes in all of them. Seven pa-
tients (patients 1, 4—7, 9, 10) had a history of icteric
hepatitis apparently followed by the onset of pro-
teinuria after varying periods of time. In patient 2,
8 the HBs antigenemia was recognized 2 years after
II the onset of the nephrotic syndrome. In the remain-
ing 3 patients, the temporal relationship between
10 the onset of the renal disease and HBV infection
17 could not be assessed.
The renal histologic changes encompassed a van-
9 ety of pathologic patterns ranging from MPGN to
4 minimal glomerular lesions (Table 3). Four patients,
3 with MPGN and 1 with DPIEGN, showed glomer-
ular deposits of Ig's and complement factors. None
of these patients showed a positive staining for
HBsAg in their kidney biopsy specimens.
HBsAg seronegative patients. Within the remain-
ing 125 HBsAg seronegative patients, the screening
for HBsAg on kidney biopsy revealed a positive
direct staining in 5 patients (Fig. 2a). Three patients
had MPGN and mixed cryoglobulinemia, which
was classified essential in 2 and associated to lyn-
phoproliferative disorder in the other one. The
other 2 patients suffered from SLE nephritis of the
diffuse proliferative type with crescents and arteri-
tis (patient 15) and of membranous type (patient 16),
respectively. The serologic data concerning these 5
patients are presented in Table 4. Serum markers of
HBV infection other than HBsAg, such as anti-HBs
and/or anti-HBc antibodies, were found in the 2
patients with EMC. The assay on the cryoglobulin
isolated fractions revealed that the anti-HBs activ-
ity pertained to the cryo-IgG in both patients, but
only in patient 12 were the anti-HBs antibodies
more concentrated in the cryoprecipitate than in the
supernatant with a ratio of 4:1. None of the cryopre-
cipitates tested contained immunoreactive HB sAg.
Table 5 reports the renal and liver immunohisto-
pathologic findings in the 5 patients with positive-
HBsAg direct staining of kidney biopsy specimen.
The blocking test with unfluoresceinated anti-HBs
serum resulted only in a slight fading of the direct
staining of HBsAg.
All had heavy deposits of IgG and 1gM, which
were distributed in a coarsely granular pattern in
the mesangium and along the capillary walls of the
glomeruli, and in I of them (patient 13), 1gM depos-
its were observed around the tubuli. The kidney
tissue specimens of these patients fixed also the
FITC-lgGagg with a distribution similar to that of
the anti-IgM fluoresceinated serum, but with a more
finely granular appearance (Fig. 2b). This reaction
was blocked by treating the renal tissue sections
-Iv
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a ND means not done.
Table 2. Laboratory data in HBsAg seropositive patientsa
Table 3. Immunohistopathologic findings in HBsAg seropositive patients
a CAH means chronic active hepatitis; CPH, chronic persistent hepatitis.
b Abbreviations are defined in Table 1.
C3,Clq,C4
C3 ,C I q,C4
with IgGagg before the incubation with the FITC-
IgGagg. The pretreatment with unconjugated anti-
human 1gM serum prevented the staining of the
tissue specimens with the FITC-IgGagg. On the
other hand, no blocking effect had the pretreatment
with the antihuman IgG, IgA, Clq, respectively, or
the exposure of the tissue sections at 600 C for 30
mm. The pretreatment of the kidney biopsy-frozen
sections with unfluoresceinated anti-IgM serum
blocked also the staining with the fluoresceinated
anti-HBs serum (Fig. 2c), but it did not alter the
staining with the fluoresceinated-specific sera
against IgG, IgA, and complement factors. Con-
trasting the results obtained with the commercial
anti-HBs fluoresceinated serum, the fluoresceinat-
ed Fab' anti-HBs preparation did not stain at all the
tissue kidney specimen of the 5 patients (Fig. 2d).
Conversely, each of the fluoresceinated anti-Ig Fab'
preparation stained the kidney tissue sections like
the corresponding fluoresceinated antisera in the 3
patients (patients 12, 15, 16) in whom enough tissue
specimen was available to perform such tests (Fig.
3,a and b).
Discussion
Our finding of a greater than expected incidence
of chronic HBs antigenemia among the patients
with various forms of glomerulonephritis, 8% com-
pared with 2.7% in the general hospitalized popula-
tion of Southern Italy (Pagliaro L, personal commu-
nication), adds to previous, similar observations to
support the hypothesis of a pathogenic relationship
between the HBV infection and glomerulonephritis,
which might be sustained by the deposition of
HBsAg immune complexes within the glomeruli [7,
81. We failed, however, to find the HBsAg within
the glomerular immunodeposits of the seropositive
patients. It should be noted that the significance of
our negative findings is mitigated by the fact that
only 4 out of II seropositive patients had immuno-
deposits within the glomeruli, several others having
glomerular lesions progressed to diffuse sclerosis, a
Sex, age Serum creatinine Urinary proteins C3 CH50 HBsAb
Patient no. yr mg/di g/day mgldi U/mi RIA U HbcAb Cryoglobulins Serum AA
1 M 54 7.1 3.0 130 ND +
2 M 63 3.5 10.7 70 ND — +
3 M 37 3.2 6.9 50 20 — ND
4 M49 2.1 3.3 72 10 — —
5 M 27 7.4 2.0 70 35 +
6 F 50 5.2 0.2 83 35 50 +
7 M 25 0.7 0.4 145 49 — +
8 F 30 0.9 0.4 53 15 — ND
9 F 27 0.9 3.8 27 10 — +
10 M46 0.8 0.3 71 50 — +
11 M50 2.9 8.0 15 10 — + +
Liver
Inclusions
Patient no. Histologya HBsAg HBcAg Histologyb Ig class Complement factors
Kidney
Glomerular deposits
I CAH - - DPIEGN
2 CPH MPGN G
3 CAH ND ND MPGN G,A,M
4 CAH + - CSGN -
5 CPH — + CSGN
6 CAH - — CSGN —
7 CPH + + MP
8 CAH - + MP -
9 Normal + - MPGN G,M
10 Normal + — DPIGN —






















Table 5. Immunohistopathologic findings in patients with positive glomerular staining for HBsAg
Liver Kidney
Inclusions
Histologya HBsAg HBcAg Histologyc
ND EMC-MPGN
CAH EMC-MPGN
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Fig. 2. Kidney tissue sections incubated with Afluor. anti-Hbs serum; B FITC-IgGagg; C unfluor. anti-IgM serum jI1owed bvfluor.
anti-HBs serum; Dfluor. anti-HBs Fab' (X360). Large fluor. clumps in C are due to serum precipitates.
Table 4. Laboratory data in patients with positive glomerular staining for HB5Ag
Patient Sex, age Serum creatinine Urinary proteins C3 CH5O HBsAb




— — trace amounts








Ig class Complement factors AA
a Abbreviations are defined in Table 3.
b Inclusions of HBsAg were present only in the Kuppfer cells.
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Fig. 3. Similar glomerular staining with Afluor. anti-IgG serum and Bfluor. anti-IgG Fub' (X360).
Fig. 4. Kidney tissue sections incubated with A fluor. anti,neasles serum: B unfluor. anli—igM serumn followed by fluor. anti,neusles
serum (X360).
stage when the immunofluorescence studies very
often are no longer informative.
Because HBsAg amid the glomerular immunode-
posits has been previously detected even in sero-
negative patients 3, 6J, we tested systematically the
kidney biopsy specimens of the glomerulonephritic
patients with the direct immunofluorescence tech-
nique for the HBsAg and found 5 cases with posi-
tive glomerular staining. It is noteworthy that the
positive findings were restricted to patients with
mixed cryoglobulinemia either essential or second-
ary to a lynphoproliferative disorder, and to pa-
tients with SLE nephritis, conditions where a much
higher than expected frequency of HBV serum
markers has been reported [7, 8, 161. in all 5
patients with positive HBsAg glomerular staining, 2
of whom had some serum HBV markers (anti-HBc
and anti-HBs), we demonstrated the presence of
antiglobulin activity within the glomeruli, which
appeared to pertain to the 1gM deposits. The detec-
tion of antiglobulin activity in every patient showing
HBsAg deposits within the glomeruli casts doubt on
the specificity of the direct immunofluorescence
reaction with the fluoresceinated anti-HBs serum.
Actually, the pretreatment with anti-IgM unconju-
gated serum of the tissue sections, which neutral-
ized the tissue antiglobulin activity, blocked also
the staining with the anti-HBs fluoresceinated se-
rum. The proof that the fixation of the fluorescein-
ated anti-HBs serum to the tissue section was
unrelated to its antibody activity was provided by
the observation that the tissue sections did not stain
at all with the fluoresceinated Fab' anti-HBs prep-
aration. These findings have been confirmed in a
larger series of patients with EMC [171.
It is known that serum AA may interfere with
several serologic reactions, including the fluores-
ceinated antibody test [181 and the complement
fixation by viruses [19], owing to its ability to bind
the Fc portion of IgG antibody molecule. Likewise,
the direct staining we observed with the anti-HBs
fluoresceinated serum could result from the binding
of the Fe fragment of fluoresceinated molecule to
the deposited 1gM with AA, a reaction probably
favoured by some degree of aggregation of the
fluoresceinated antibodies. In subsequent studies,
summarized in the Appendix, we showed that a
similar reaction can occur with fluoresceinated anti-
bodies having other specificities.
The pretreatment of the tissue sections with
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unconjugated anti-IgM serum did not prevent the
staining for IgG, IgA, and complement factors with
the specific fluoresceinated antisera as it did with
the anti-HBs fluoresceinated antiserum. This obser-
vation suggests that those moieties were truly de-
posited in the glomeruli: indeed, the studies with
the anti-Ig's fluoresceinated Fab's confirmed the
results of the blocking experiments.
Because of our observations, previous claims
about the occurrence of HBsAg glomerulonephritis
should be critically reappraised. In these studies [1—
61, the antiglobulin activity of 1gM deposits within
the glomeruli was not looked for. Such activity has
been found even in the glomeruli of patients with no
detectable serum AA 1114, 15], and it cannot be
excluded that some of the reported HBsAg glomer-
ular-positive staining were due to the interference
of 1gM glomerular deposits with anti-lgG activity.
Moreover, to demonstrate the presence of HBsAg
within the glomeruli, some investigators [1—3, 5]
used the indirect immunofluorescence technique,
which may be misleading when deposits of lgG are
present in the glomeruli.
Even though we failed to find a single instance of
HBsAg in the glomeruli of 136 patients with various
forms of glomerulonephritis, this cannot be taken as
definitive evidence for ruling out an etiologic role of
HBV infection in some form of glomerulonephritis.
The possibility should be considered that immune
complexes associated with HBV infection other
than those containing HB5Ag can mediate the de-
velopment of the glomerulonephritis, or that the
HBsAg complexes in glomeruli are in antibody
excess, thereby preventing the detection of the
antigen with the specific fluoresceinated antiserum.
Appendix
To assess whether the glomerular deposits of antiglobulin
activity can interfere with other types of irnmunofluorescence
staining as well as with that for HBsAg, we carried out supple-
mentary studies on another group of 7 patients with antiglobulin
deposits in their gloineruli (6 had GN associated with EMC, 1
SLE GN). In addition to the fluorescence examination for
HBsAg, antiglobulin factor, Ig classes, and complement factors,
the kidney biopsy specimens of the new patients were tested
with rabbit fluoresceinated monospecific sera against measles
and mumps (both purchased from Eurobio, Paris, France).
As controls, 40 antiglobulin negative renal biopsies obtained
from patients with various form of GN were similarly examined.
Of the 7 kidney biopsies with antiglobulin deposits, I was
positive for all three viruses, 3 for two viruses (HB5Ag and
measles), 2 for one virus (either HBsAg or measles), 1 was
negative for all three viruses. All the positive viral stainings were
blocked by previously neutralizing the antiglobulin deposits with
the unconjugated anti-lgM serum, as in the example shown in
Fig. 4,a,b. The biopsy specimen from the control group did not
stain with any of the antiviral sera. These findings show that the
antiglobulin deposits in the kidney interfere with other types of
immunolluorescence reactions as well as with that for HBsAg.
It has been shown that the 1gM anti-IgG fractions obtained
from the sera of different patients display broad reactivity
patterns for isologous, omologous, and heterologous IgG, such
that each specificity profile was never exactly like any of the
others [20—22]. Accordingly, it comes as no surprise that the
renal 1gM antiglobulin deposits react in an unpredictable way
when tested with a panel of rabbit fluoresceinated IgG antigens
having different antibody specificities.
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